Ana Teresa Azevedo Sachetto

Dr. Ana Teresa Azevedo Sachetto

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
CTCamila Martos Thomazini
Camila Martos Thomazini
ASAna Teresa Azevedo Sachetto
Ana Teresa Azevedo Sachetto
CACynthia Zaccanini de Albuquerque
Cynthia Zaccanini de Albuquerque
VMVânia Gomes de Moura Mattaraia
Vânia Gomes de Moura Mattaraia
AOAna Karina Oliveira
Ana Karina Oliveira
MSMarcelo Larami Santoro
Marcelo Larami Santoro
Patients bitten by snakes consistently manifest a bleeding tendency, in which thrombocytopenia, consumption coagulopathy, mucous bleeding, and, more rarely, thrombotic microangiopathy, are observed. Von Willebrand factor (VWF) is required for primary hemostasis, and some venom proteins, such as botrocetin (a C-type lectin-like protein) and snake venom metalloproteinases (SVMP), disturb the normal interaction between platelets and VWF, possibly contributing to snakebite-induced bleedings. To understand the relationship among plasma VWF, platelets, botrocetin and SVMP from Bothrops jararaca snake venom (BjV) in the development of thrombocytopenia, we used (a) Wistar rats injected s.c. with BjV preincubated with anti-botrocetin antibodies (ABA) and/or Na2-EDTA (a SVMP inhibitor), and (b) VWF knockout mice (Vwf-/-) injected with BjV. Under all conditions, BjV induced a rapid and intense thrombocytopenia. In rats, BjV alone reduced the levels of VWF:Ag, VWF:CB, high molecular weight multimers of VWF, ADAMTS13 activity, and factor VIII. Moreover, VWF:Ag levels in rats that received BjV preincubated with Na2-EDTA and/or ABA tended to recover faster. In mice, BjV caused thrombocytopenia in both Vwf-/- and C57BL/6 (background control) strains, and VWF:Ag levels tended to decrease in C57BL/6, demonstrating that thrombocytopenia was independent of the presence of plasma VWF. These findings showed that botrocetin present in BjV failed to affect the extent or the time course of thrombocytopenia induced by envenomation, but it contributed to decrease the levels and function of plasma VWF. Thus, VWF alterations during B. jararaca envenomation are an ancillary event, and not the main mechanism leading to decreased platelet counts.

1 December 2022 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
NMNigel Mackman
Nigel Mackman
ASAna Teresa Azevedo Sachetto
Ana Teresa Azevedo Sachetto
The coronavirus 2019 (COVID-19) pandemic is caused by severe acute respiratory syn-drome coronavirus 2 (SARS-CoV-2) virus. Infection with SARS-CoV-2 is associated with acute respiratory distress syndrome, thrombosis and a high rate of mortality. Thrombotic events increase with severity. Tissue factor (TF) expression is increased during viral and bacterial infections. This review summarizes studies that have examined TF expression in response to SARS-CoV-2 infec-tion. SARS-CoV-2 virus and its proteins upregulate TF mRNA, protein and activity in a variety of cells, including bronchial epithelial cells, neutrophils, monocytes, macrophages, endothelial cells and adventitial fibroblasts. COVID-19 patients have increased TF expression in lungs, bron-choalveolar lavage fluid and circulating extracellular vesicles. The increase in TF was associated with coagulation activation markers, thrombosis, inflammatory markers, severity of disease and mortality. Taken together, the studies suggest that TF plays a central role in thrombosis in COVID-19. TF may be a useful prognostic marker and therapeutic target to reduce thrombosis and inflam-mation.

31 July 2024 in Blood Vessels, Thrombosis & Hemostasis
Verified
Journal Article
Open access
NMNigel Mackman
Nigel Mackman
ASAna Teresa Azevedo Sachetto
Ana Teresa Azevedo Sachetto
Tissue factor (TF) is a transmembrane protein that, in association with its ligand factor VII (FVII)/activated factor VII (FVIIa), activates blood coagulation. TF is highly procoagulant and even very small amounts can activate blood coagulation. Levels of TF–positive extracellular vesicles (EVs) are increased in blood in diseases associated with thrombosis. However, it is challenging to accurately quantify the very low levels of TF in blood. Activity-based assays have higher sensitivity and specificity than antigen-based assays. Many anti-human TF antibodies have been generated but they differ in their affinity for TF and bind to different epitopes. They can be divided into 2 groups: those that compete with FVII/FVIIa binding to TF, and those that bind to both TF and the TF-FVII/VIIa complex. Commercial enzyme-linked immunosorbent assays are commonly used to measure TF antigen in plasma but have low sensitivity and specificity for the detection of TF antigen in plasma. Flow cytometry is used to measure TF antigen on EVs but also has low sensitivity and specificity. Functional TF activity assays should be performed in the presence and absence of an inhibitory anti-TF antibody to distinguish between TF-dependent and TF-independent FXa generation because FVIIa can activate FX in the absence of TF. TF pathway inhibitor inhibits the TF-FVIIa complex and reduces TF activity of isolated EVs. Two commercial assays are available for the measurement of TF activity of EVs isolated from human plasma. Measurement of TF activity of EVs isolated from plasma may be a useful biomarker of thrombotic risk in different diseases.

27 June 2025 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
ACALISON CHAVES
ALISON CHAVES
BBBianca Carla Silva Campitelli Barros
Bianca Carla Silva Campitelli Barros
MCMiguel Cosenza-Contreras
Miguel Cosenza-Contreras
MMMariana S.L.C. Morone
Mariana S.L.C. Morone
ASAna Teresa Azevedo Sachetto
Ana Teresa Azevedo Sachetto
SSSolange M. T. Serrano
Solange M. T. Serrano
Animal venoms comprise many toxins that work in concert to break apart the robust homeostatic systems of prey organisms. Conversely, prey organisms actively antagonize each step of envenoming, which displays a complex kinetics involving important changes at molecular, cell, tissue, and organism levels. In this study we explored the mammalian host response to envenoming using proteomics/N-terminomics and phosphoproteomics approaches to evaluate the in vivo effects of Bothrops jararaca venom in the mouse kidney after injection in the thigh muscle (1.6 mg/kg), mimicking a snakebite, and the impact of anti-Bothrops antivenom injected 1 h later (1.6 mg/kg; i.v. tail). For proteomics/N-terminomics, proteins were TMT-labeled, in order to allow for specific (tryptic) and semi-specific searches of MS/MS spectra to assess both global proteome and degradome. We quantified > 7,000 proteins and prominent changes were observed in the kidney tissue, where protein differential abundance was identified after 3, 6 and 24 h, including markers of acute-phase response and injury. Likewise, the N-terminomic analysis revealed a significant impact of venom progressing from 3 h to 24 h, resulting in dysregulated proteolysis, and indicating the activation of host proteases. The protease fingerprint matched legumain and cathepsin profiles. Venom toxins also promoted alteration in the dynamics of phosphorylation, with the activation of kinases. Under the conditions tested, antivenom administration (i) did not reduce the number of differentially abundant proteins and inflammation markers, (ii) partially attenuated the generation of proteolytic products in envenomed animals, and (iii) directly perturbed the phosphorylation signaling in control animals. Taken together, our findings underscore for the first time the mouse renal response to a protease-rich venom, revealed by the dynamic alteration of protein abundance, protease targets and phosphorylation events, providing new facets of snake venom and antivenom systemic effects, which are important for the development of new therapies.

24 April 2025 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
ASAna Teresa Azevedo Sachetto
Ana Teresa Azevedo Sachetto
SASierra J. Archibald
Sierra J. Archibald
MPMegan Perkins
Megan Perkins
GZGuoying Zhang
Guoying Zhang
YZYan Zhang
Yan Zhang
NMNigel Mackman
Nigel Mackman